Glioma: all 1,425 studies
Page 15 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsCompletedNCT00004688Phase 2
- Temozolomide in Treating Patients With Recurrent or Progressive Malignant GliomaStatus unknownNCT00004204Phase 2
- Temozolomide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004113Phase 2
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
- Gene Therapy in Treating Patients With Recurrent Malignant GliomasCompletedNCT00004041Phase 1
- Carmustine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004028Phase 1
- Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaCompletedNCT00003935Phase 1
- Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaCompletedNCT00003909Phase 1
- Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant GliomaCompletedNCT00003876Phase 1
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem GliomaCompletedNCT00003625Phase 1
- Irinotecan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00003616Phase 1/2
- Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant GliomasWithdrawnNCT00003564Phase 3
- Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade GliomaCompletedNCT00003467Phase 2
- Temozolomide in Treating Patients With Progressive Low-Grade GliomaCompletedNCT00003466Phase 2
- Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade GliomasCompletedNCT00003463Phase 1
- Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00003301Phase 1/2
- Temozolomide and Carmustine in Treating Patients With Anaplastic GliomaCompletedNCT00003176Phase 2
- Irinotecan in Treating Patients With Recurrent GliomaCompletedNCT00003134Phase 2
- Biological Therapy in Treating Patients With Primary or Advanced GliomaSuspendedNCT00003067Phase 2
- Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade GliomaStatus unknownNCT00003015Phase 3
- Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant GliomaCompletedNCT00002988Phase 1
- Chemotherapy in Treating Patients With Recurrent Malignant GliomaCompletedNCT00002986Phase 1
- O(6)-Benzylguanine in Treating Patients With Malignant GliomaCompletedNCT00002971Phase 1
- Monoclonal Antibody Therapy in Treating Patients With Recurrent GliomasCompletedNCT00002753Phase 1
- Carboplatin in Patients With Progressive GliomasCompletedNCT00002749Phase 2